Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Spain's Almirall warns of delay in approval for psoriasis drug
Spanish pharma company Almirall said on Tuesday it expects the launch of psoriasis treatment drug, Tildrakizumab, in Europe to get delayed by at least six months due to regulatory hurdles.
Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195
STAMFORD, Conn.
Cost of diabetes epidemic reaches $850 billion a year
(Reuters) - The number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $850 billion a year, medical experts said on Tuesday.
Kadmon Initiates Phase 2 Placebo-Controlled Clinical Trial of Tesevatinib in Autosomal Dominant Polycystic Kidney Disease
NEW YORK, NY, USA I November 13, 2017 I Kadmon Holdings, Inc.
California Institute of Biomedical Research and Excelra Knowledge Solutions Enter into Database Licensing Agreement
HYDERABAD, India--(BUSINESS WIRE)--Excelra Knowledge Solutions Pvt.
Nanotech, gene editing used to edit cholesterol gene: U.S. study
CHICAGO (Reuters) - U.
Bill Gates makes $100 million personal investment to fight Alzheimer's
LONDON, Nov 13 (Reuters) - Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and governm...
Dr. Reddy's launches generic Vidaza in Canada
PRINCETON, N.
M&As this week: Egyptian American Enterprise Fund, Valeant Pharmaceuticals International
US-based private equity firm Egyptian American Enterprise Fund (EAEF) has acquired 46.
Cerenis Therapeutics to acquire Lypro Biosciences assets
Biopharmaceutical company Cerenis Therapeutics is set to acquire Lypro Biosciences assets, a portfolio of drug delivery nanotechnology.
Sanofi in $675 million deal to expand multiple sclerosis franchise
French pharma major Sanofi (Euronext.
Trump poised to nominate ex-Lilly executive Alex Azar for top HHS job: report
Despite blasting pharma for "getting away with murder" on multiple occasions, President Donald Trump is expected to pick a former pharmaceutical executive to lead the Department of Health an...
477
478
479
480
481
482
483
484
485
